Podcast: How Alcidion is raising the bar in patient healthcare

  Article   Archived

PUBLISHED: 09-05-2019 13:46 p.m.

1 minute read

Hey! Looks like you have stumbled on an old article that is archived from our old business model.

In 2019 the original founding team returned to run Next Investors, we launched a managed investment fund where we only write about stocks we carefully research and are invested in for the long term - see our current investment portfolio here.

The below article was written under our previous business model but we have kept it kept online for your reference - read more about the Next Investors evolution to a managed investment fund.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers. - click here to read how our current business model works.

Alcidion Group Limited (ASX:ALC) ­­is leading the way in healthcare informatics — a particularly lucrative area of healthcare that’s undergoing a rapid shift to digital patient data, driven by the need for real-time healthcare analytics.

Having experienced an impressive share price run, gaining more than 150% since early March, the company’s potential in this space is starting to gain recognition.

In this Next Tech Stock podcast Alcidion Group (ASX:ALC) Managing Director Kate Quirke speaks with Meagan Evans discussing recent developments, the quarterly report, and what’s ahead for the group into FY20.


Just as a reminder, here's why we like Alcidion as an investment.

7 reasons to consider for an investment in Alcidion

Alcidion’s health informatics technology products — Patientrack, Miya and Smartpage — and specialist IT services are being adopted by major hospital groups worldwide. The company’s revenues are on the rise and it is cash flow positive.

It seems that ALC really is ‘Changing the Game in Real-Time Healthcare Analytics’ and we expect plenty more to come.